Phase 2 safety trial targeting amyloid beta production with a gamma-secretase inhibitor in Alzheimer disease.
Fleisher AS; Raman R; Siemers ER; Becerra L; Clark CM; Dean RA; Farlow MR; Galvin JE; Peskind ER; Quinn JF; Sherzai A; Sowell BB; Aisen PS; Thal LJ; Archives Of Neurology, 2008, vol. 65, issue 8, p 1031, ISSN 15383687. ISBN 15383687.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef